NEU 3.32% $20.52 neuren pharmaceuticals limited

Note a lot of this is driven by rare oncology diseases and that...

  1. 264 Posts.
    lightbulb Created with Sketch. 12
    Note a lot of this is driven by rare oncology diseases and that too by the checkpoint inhibitors anti PD-1's like the Keytruda's and the Opdivo's and the Yervoys and the Car-T's again for oncology. That does push the averages up.
    Last edited by nikki: 10/03/17
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.